Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Change in Cash (2016 - 2025)

InspireMD (NSPR) has 16 years of Change in Cash data on record, last reported at $51.9 million in Q3 2025.

  • For Q3 2025, Change in Cash rose 512.94% year-over-year to $51.9 million; the TTM value through Sep 2025 reached $47.6 million, up 2304.5%, while the annual FY2024 figure was $9.3 million, 85.22% up from the prior year.
  • Change in Cash reached $51.9 million in Q3 2025 per NSPR's latest filing, up from -$874000.0 in the prior quarter.
  • Across five years, Change in Cash topped out at $51.9 million in Q3 2025 and bottomed at -$28.4 million in Q3 2021.
  • Average Change in Cash over 5 years is $2.7 million, with a median of -$874000.0 recorded in 2025.
  • Peak YoY movement for Change in Cash: skyrocketed 1422.76% in 2021, then plummeted 2502.79% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$1.1 million in 2021, then surged by 166.16% to $698000.0 in 2022, then plummeted by 701.58% to -$4.2 million in 2023, then skyrocketed by 173.78% to $3.1 million in 2024, then soared by 1575.08% to $51.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $51.9 million in Q3 2025, -$874000.0 in Q2 2025, and -$6.5 million in Q1 2025.